AstraZeneca’s Imfinzi (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) was approved in the U.S. for the treatment of adult ...

Johnson & Johnson entered into a definitive agreement to acquire Halda Therapeutics OpCo for $3.05 billion in cash. Eli Lilly announced it will pay $40 million upfront and up to $2.56 billion in a ...

Homer City Generation ("HCG")1 today announced that the Pennsylvania Department of Environmental Protection ("PA DEP") has issued air quality plan approval, commonly referred to as an "Air Permit," ...

A Pre-Submission focused on sterilization was recently filed with the FDA, introducing the Agency to the Company’s enhanced Electron Beam (E-Beam) sterilization process for the RadioGel hydrogel and ...

The Chronos boss fight is, by far, the most difficult challenge you will face in Hades 2. Once you finally deplete his health bar in Tartarus and are no doubt starting to rejoice, Chronos pulls yet ...

CastleVax, a clinical-stage biotechnology company developing intranasal vaccines using its attenuated Newcastle Disease Virus (NDV)-based vaccine platform, announced today that the first participant ...

Prothena (PRTA) announced the publication of Phase 2 clinical trial data for coramitug for the treatment of ATTR amyloidosis with cardiomyopathy ...

(MENAFN- GlobeNewsWire - Nasdaq) Dubai, UAE, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM) continues to advance steadily through its development roadmap, completing its Phase 2 milestones as ...

NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of ...

New Delhi [India], November 7 (ANI): Prime Minister Narendra Modi sounding the poll bugle in Bihar's Aurangabad on Friday, took a sarcastic jab at the Opposition's 'rift-ridden' Mahagathbandhan ...

The battelines are drawn, positions taken, speeches delivered, and dice cast: in the next few hours, campaigning for the second and last phase of the Assembly polls in Bihar will come to an end. The ...

NervGen will meet with the FDA early next year to align on a regulatory path forward for NVG-291 in chronic spinal cord ...